Kinnate Biopharma Price on March 8, 2023

Kinnate Biopharma Valuation on March 8, 2023

Kinnate Biopharma Trading Date Momentum on March 8, 2023

On March 09 2023 Kinnate Biopharma was traded for  3.91  at the closing time. The top price for the day was 4.52  and the lowest listed price was  3.79 . The trading volume for the day was 108.7 K. The trading history from March 9, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 12.13% . The trading delta at closing time against the current closing price is 21.12% .

Kinnate Biopharma Fundamentals Correlations and Trends

By evaluating Kinnate Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kinnate Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kinnate financial account trend analysis is a perfect complement when working with valuation or volatility modules.

Kinnate Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kinnate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kinnate Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kinnate Biopharma stock prices may prove useful in developing a viable investing in Kinnate Biopharma

Kinnate Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how Kinnate Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kinnate Biopharma shares will generate the highest return on investment. By undertsting and applying Kinnate Biopharma stock market strength indicators, traders can identify Kinnate Biopharma entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for Kinnate Biopharma's price direction in advance. Along with the technical and fundamental analysis of Kinnate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kinnate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.